EUDAMED – REGISTRATION OF LEGACY DEVICES

“Legacy devices” are medical devices, covered by a valid Medical Device Directive certificate (Declaration of Conformity for class I medical…

READ

DIGITAL APPLICATION DATASET INTEGRATION (DADI) NETWORK PROJECT

The Digital Application Dataset Integration (DADI) is a Network Project led by the EMA to transform and optimise regulatory procedure…

READ

PUBLICATION OF THE UPDATED AGREEMENT TEMPLATE BY THE NATIONAL COORDINATION CENTER OF ETHICS COMMITTEES FOR CLINICAL TRIALS ON MEDICINES FOR HUMAN USE AND ON MEDICAL DEVICES

The National Coordination Center of Ethics Committees for clinical trials on medicines for human use and on medical devices has…

READ

SUNSET CLAUSE IN ITALY: CURRENT REGULATION AND EXEMPTION REQUEST

According to the Legislative Decree 219/2006 (art.38), any Marketing Authorisation of National/MRP/DCP medicinal products ceases to be valid: In case…

READ

PERSON RESPONSIBLE FOR REGULATORY COMPLIANCE FOR MEDICAL DEVICES

The presence of at least a Person Responsible for Regulatory Compliance (PRRC) is one of the new regulatory obligations introduced…

READ

RARE DISEASES AND ORPHAN DRUGS IN ITALY

On 27th November 2021, a new piece of legislation on rare diseases was published in the Italian Official Journal (Law…

READ

ADVERTISING OF OTC/SOP MEDICINAL PRODUCTS FOR GENERAL PUBLIC ON SOCIAL MEDIA

The responsible Authority for the evaluation of the advertising concerning OTC/SOP medicinal products on social medial in Italy is the…

READ

MDCG 2022 – 5 GUIDANCE ON BORDERLINE BETWEEN MEDICAL DEVICES AND MEDICINAL PRODUCTS UNDER REGULATION (EU) 2017/745 ON MEDICAL DEVICES

The Medical Device Coordination Group (MDCG) recently published the Guidance on borderline between medical devices and medicinal products under Regulation…

READ

RULES AND PROCEDURES TO ACCESS THE AIFA NATIONAL FUND FOR ORPHAN DRUGS

Law 326/2003 provided for the establishment of a national fund at AIFA for the use of “orphan drugs and for…

READ

PHARMACOECONOMIC AND BUDGET IMPACT ANALYSES SUBMITTED TO AIFA – REPORT 2021

In accordance with the new AIFA Guidelines entered into force on 30 December 2020, the Applicant has to submit pharmacoeconomic…

READ